Unraveling the role of PREX2 mutations as a biomarker for immunotherapy response in colorectal cancer
{{output}}
IntroductionImmunotherapy benefits gastrointestinal tumor patients. But traditional biomarkers like TMB and MSI can't precisely identify beneficiaries. Phosphatidylinositol - 3,4,5 - triphosphate - dependent Rac exchange factor 2 (PREX2) plays a complex role ... ...
